Our goals are to develop therapeutics targeting the chemokine network in inflammatory diseases affecting the heart, blood vessels and other organ systems. Developing new therapeutics that target the chemokine network in inflammation is the major focus of our laboratory, which is based at the Wellcome Centre for Human Genetics. Although inflammation is a fundamental host-defence response that serve